Search results
Results From The WOW.Com Content Network
RPG Life Sciences (RPGLS) is an Indian pharmaceutical company, formerly known as Searle (India) Ltd. Its three major sources of business are manufacturing and marketing of bulk drugs, also known as API (Active Pharmaceutical Ingredients), pharmaceutical formulation and fermentation & biotechnology.
Joint stability refers to the resistance offered by various musculoskeletal tissues that surround a skeletal joint. Several subsystems ensure the stability of a joint.
RPG Life Sciences (RPGLS) is an Indian pharmaceutical company. Formerly known as Searle (India) Ltd, RPG Life Sciences is part of RPG Enterprises. [3] It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as API (active pharmaceutical ingredients ...
A special and by far less common form of joint-stock companies, intended for companies with a large number of shareholders, is the publicly traded joint-stock companies, called allmennaksjeselskap and abbreviated ASA. A joint-stock company must be incorporated, has an independent legal personality and limited liability, and is required to have ...
Piramal Pharma Limited is active in business verticals including pharmaceuticals, healthcare and life sciences.Its business divisions include Piramal Pharma Solutions, a contract development and manufacturing organization; Piramal Critical Care, a manufacturer of inhalational anesthetics and other hospital generics; and Piramal Consumer Products Division, an over-the-counter consumer ...
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
On Tuesday, Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 ...
In October 2018, a unit of the company, Changchun Changsheng Life Sciences Ltd was fined 9.1 billion Yuan ($1.32 billion) for falsifying data for a rabies vaccine and producing an ineffective vaccine for babies. 14 of its executives were banned from working in the drugs sector. It was separately fined 600,000 yuan by the China Securities and ...